Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success
Quanterix Director of Medical Affairs discusses the advances revolutionizing Alzheimer’s diagnosis and care
Neuro-Bio is creating a first-of-its-kind diagnostic, targeting a novel biomarker in Alzheimer’s Disease
This assay allows for the quantitative measurement of soluble sTREM2 in human cerebrospinal fluid and blood within just 35 minutes
Radiometer’s blood gas and immunoassay POC analysers deliver critical parameters enabling critical care teams to make quick decisions fast
Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years
Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, neurofilament and APOE genotype in Alzheimer’s disease diagnostics
Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field
From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing
Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research
The test operates using the company’s fully automated Lumipulse G1200 instrument system
Crown Bioscience to deliver clinical-grade testing, further strengthening its support for clients' clinical and translational drug development efforts
By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale
The use of protein biomarkers in oncology is growing rapidly and offers real hope to patients with hard-to-treat cancers
The first cleared troponin assay in the U.S. for longer-term prognostic insights
Experts from Chan Zuckerberg Initiative, FDA, AbbVie, Elsevier, Penn Medicine, Takeda and others discuss patient-centricity, data standards, and copyright
Research results highlight how the Idylla™ System allows for the analysis of small biological samples, including cytological specimens, giving healthcare providers critical information within hours so they can make timely treatment decisions
Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine
APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s
Roche obtains CE certification for VENTANA CLDN18 (43-14A) RxDx Assay to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
Find out how CLINICAL24 Ambassador, Dr. Frank Peacock, is advancing cardiovascular care through clinical trials in acute coronary syndrome and heart failure, driving progress in emergency medicine
